(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-acetamidopentanoic acid, 98%, 25g

But-2-ene-1,4-diyl diacetate, 95.0%, 5g

1-Acetyl-5-bromo-4-chloro-1H-indol-3-yl acetate, 95.0%, 250mg

3,5-Difluoro-4-formylbenzoic acid, 95.0%, 1g

Étuve Heratherm Advanced Protocol avec ventilateur de circulation, 170 l, OMH180, 1 pièce

(R)-1-(4-(((tert-butyldimethylsilyl)oxy)methyl)cyclohexyl)-N-((R)-1-phenylethyl)ethanamine, 97%, 1g

Acide 5,5'-dithio-bis-(-2-nitrobenzoïque), min 98 %, pa, 25 g, emballage en verre

8-Methoxy-3,4-dihydro-2H-benzo[b][1,4]oxazine, 97%, 100mg

1,4,8,11-Tetraacyclotetradecane, 95.0%, 5g

TERT-BUTYL 3-HYDROXY-4-((TOSYLOXY)METHYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

Filtres seringues CHROMAFIL® MV, 0,2 µm, 100 Pièce(s)

(3-Bromo-2,5-difluorophenyl)methanol, 95.0%, 250mg

6-Bromo-2,2-dimethylchroman-4-amine, 95%, 100mg